Lower the systolic BP, lesser the risk of hypertension complication : Study

Published On 2015-10-15 08:11 GMT   |   Update On 2015-10-15 08:11 GMT

Washington D.C, Oct 14: A new study has revealed that lowering systolic blood pressure below the currently recommended target can reduce the risk of left ventricular hypertrophy (LVH), the most common complication of high blood pressure.LVH, the enlargement and thickening of the walls of the left ventricle, the heart's main pumping chamber, is associated with an increased risk of heart...

Login or Register to read the full article
Washington D.C, Oct 14: A new study has revealed that lowering systolic blood pressure below the currently recommended target can reduce the risk of left ventricular hypertrophy (LVH), the most common complication of high blood pressure.

LVH, the enlargement and thickening of the walls of the left ventricle, the heart's main pumping chamber, is associated with an increased risk of heart failure, stroke and even sudden cardiac death.

Although doctors have known that reversal of LVH can be achieved by sustained lowering of systolic blood pressure - the upper number on a blood pressure reading - it wasn't known if a strategy aimed at lowering blood pressure beyond the recommended level would reduce the risk.

The study provides evidence that making less than 120 the target systolic blood pressure in people with hypertension and diabetes reduces LVH, researcher Elsayed Z. Soliman, adding that lowering blood pressure even below the standard is good for heart muscle.

This, he added, is in line with the recent report from the SPRINT trial showing that blood pressure lowering below 120 mmHg reduces cardiovascular events by almost a third, as compared to the target systolic pressure of 140 mmHg.

The study is published in the early online edition of Hypertension
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News